PMCTPharmaCountry
    Home

POTELIGEO 4 mg/mL, solution à diluer pour perfusion

KK
KYOWA KIRIN HOLDINGS
Marketing Authorization Holder · Finished Dosage FormsFlag of NLNetherlands
Rx

Basic Information

Category

Finished Dosage Forms

Subcategory & Sub-subcategory

Other/Unclassified Dosage Forms / Other Unclassified Dosage Forms

Trade Type

Sell

Product Name

POTELIGEO 4 mg/mL, solution à diluer pour perfusion

Details

MOGAMULIZUMAB 4 mg

Substance

Mogamulizumab

Registered Market

Specifications

  • Dosage Form: Concentrate for solution
  • Packaging: 1 bottle in glass of 5 mL

Documents

Drug Marketing Authorization Number
Document No.: 62292771
Issue Date: Nov 22, 2018
Filters:
Sort by:

    No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Explore More

Similar Products & Services

Products & Services related to what you're viewing

Explore More

People Also Viewed

Other products & services viewed by people who looked at this product

Discover More